Epigenetic Mechanisms of the Influence of Physical Activity on the Development of Atherosclerosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

This work is an analytical review dedicated to the search for driver mechanisms of epigenetic changes in atherosclerosis pathogenesis. The disease affects the cardiovascular system in the adult population, mainly the elderly and senile. Atherosclerosis is accompanied by progressive deposition of cholesterol and lipoproteins in vessels intima with inflammation, narrowing of the lumen and impaired blood supply to tissues and organs. These processes are characterized by changes in the expression of CACNA1C, GABBR2, TCF7L2, DCK, NRP1, PBX1, FANCC, CCDC88C, TCF12, ABLIM1 genes. Prevention of atherosclerosis is physical activity, the mechanisms of which are not fully understood. Experimental models have shown that regular training not only has a protective effect on the development of atherosclerosis, but also inhibits the progression of an already developed disease with a decrease in vascular stenosis, an increase in the concentration of collagen and elastin and matrix metalloproteinases in plaques. These results have been confirmed by clinical studies. The purpose of this review was to systematize the accumulated results on the causes of epigenetic changes, including those under the influence of regular training, causing changes in the expression of specific microRNAs in atherosclerosis. It was found that physical exercise in Apo-/- mice increases the expression of miR-126 and miR-146a (inhibiting the TLR4 and TRAF genes), miR-20a (affecting PTEN), miR-492 (suppressing RETN gene mRNA). Clinical studies have shown an increase in the levels of miR-146a, miR-126, miR-142-5p, miR-424-5p and a decrease in the transcription of miR-15a-5p, miR-93-5p, miR-451 under the influence of aerobic training. It has been suggested that the drivers of epigenetic changes in atherosclerosis are transposons pathologically activated during aging, the transcription of which can change under the influence of physical training, which is accompanied by impaired expression of long non-coding RNAs and microRNAs derived from transposons. Analysis of the literature data allowed us to identify 36 such microRNAs, 25 of which showed identical changes in levels during aging and atherosclerosis.

Full Text

Restricted Access

About the authors

R. N. Mustafin

Bashkir State Medical University

Author for correspondence.
Email: ruji79@mail.ru
Russian Federation, Ufa, 450008

E. K. Khusnutdinova

Institute of Biochemistry and Genetics Ufa Federal Research Centre, Russian Academy of Sciences

Email: ruji79@mail.ru
Russian Federation, Ufa, 450054

References

  1. Herrington W., Lacey B., Sherliker P. et al. Epidemiology of atherosclerosis and the potential to reduce the global burden of Atherothrombotic Disease // Circ. Res. 2016. V. 118. P. 535–546. doi: 10.1161/CIRCRESAHA.115.307611
  2. Wang J.C., Bennett M. Aging and atherosclerosis: Mechanisms, functional consequences, and potential therapeutics for cellular senescence // Circ. Res. 2012. V. 111. P. 245–259. doi: 10.1161/CIRCRESAHA.111.261388
  3. Franceschi C., Bonafe M., Valensin S. et al. Inflamm-agning. An evolutionary perspective on immunosenescence // Ann. N. Y. Acad. Sci. 2000. V. 908. P. 244–254. doi: 10.1111/j.1749-6632.2000.tb06651.x
  4. Menghini R., Stohr R., Federici M. MicroRNAs in vascular aging and atherosclerosis // Ageing Res. Rev. 2014. V. 17. P. 68–78. doi: 10.1016/j.arr.2014.03.005
  5. De Yebenes V.G., Briones A.M., Martos-Folgado I. et al. Aging-associated miR-217 aggravates atherosclerosis and promotes cardiovascular dysfunction // Arterioscler. Thromb. Vasc. Biol. 2020. V. 40. P. 2408–2424. doi: 10.1161/ATVBAHA.120.314333
  6. Incalcaterra E., Accardi G., Balistreri C.R. et al. Pro-inflammatory genetic markers of atherosclerosis // Curr. Atheroscler. Rep. 2013. V. 15. doi: 10.1007/s11883-013-0329-5
  7. Wassel C.L., Lamina C., Nambi V. et al. Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium // Atherosclerosis. 2012. V. 222. P. 138–147. doi: 10.1016/j.atherosclerosis.2012.01.039
  8. Mishra A., Malik R., Hachiya T. et al. Stroke genetics informs drug discovery and risk prediction across ancestries // Nature. 2022. V. 611. P. 115–123. doi: 10.1038/s41586-022-05165-3
  9. Nikpay M., Goel A., Won H.H. et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease // Nat. Genet. 2015. V. 47. P. 1121–1130. doi: 10.1038/ng.3396
  10. Xu S., Pelisek J., Jin Z.G. Atherosclerosis is an epigenetic disease // Trends. Endocrinol. Metab. 2018. V. 29. P. 739–742. doi: 10.1016/j.tem.2018.04.007
  11. Deng S., Wang H., Jia C. et al. MicroRNA-146a induces lineage-negative bone marrow cell apoptosis and senescence by targeting polo-like kinase 2 expression // Arterioscler. Thromb. Vasc. Biol. 2017. V. 37. P. 280–290.
  12. Nowak W.N., Deng J., Ruan X.Z. et al. Reactive oxygen species generation and atherosclerosis // Arterioscler. Thromb. Vasc. Biol. 2017. V. 37.
  13. Bennett M.R., Sinha S., Owens G.K. Vascular smooth muscle cells in atherosclerosis // Circ. Res. 2016. V. 118. P. 692–702. doi: 10.1161/CIRCRESAHA.115.306361
  14. Chen C., Yan Y., Liu X. MicroRNA-612 is downregulated by platelet-derived growth factor-BB treatment and has inhibitory effects on vascular smooth muscle cell proliferation and migration via directly targeting AKT2 // Exp. Ther. Med. 2018. V. 15. P. 159–165. doi: 10.3892/etm.2017.5428
  15. Lu Y., Thavarajah T., Gu W. et al. Impact of miRNA in atherosclerosis // Arterioscler. Thromb. Vasc. Biol. 2018. V. 38. doi: 10.1161/ATVBAHA.118.310227
  16. Arora M., Kaul D., Sharma Y.P. Human coronary heart disease: Importance of blood cellular miR-2909 RNomics // Mol. Cell. Biochem. 2014. V. 392. P. 49–63. doi: 10.1007/s11010-014-2017-3
  17. Cui Y., Wang L., Huang Y. et al. Identification of key genes in atherosclerosis by combined DNA methylation and miRNA expression analyses // Anatol. J. Cardiol. 2022. V. 26. P. 818–826. doi: 10.5152/AnatolJCardiol.2022.1723
  18. Chalertpet K., Pin-On P., Aporntewan C. et al. Argonaute 4 as an effector protein in RNA-directed DNA methylation in human cells // Front. Genet. 2019. V. 10. doi: 10.3389/fgene.2019.00645
  19. Ouimet M., Ediriweera H., Afonso M.S. et al. MicroRNA-33 regulates macrophage autophagy in atherosclerosis // Arterioscler. Thromb. Vasc. Biol. 2017. V. 37. P. 1058–1067.
  20. Yang H., Sun Y., Li Q. et al. Diverse epigenetic regulations of macrophages in atherosclerosis // Front. Cardiovasc. Med. 2022. V. 9. doi: 10.3389/fcvm.2022.868788
  21. Sharma A.R., Sharma G., Bhattacharya M. et al. Circulating miRNA in atherosclerosis: A clinical biomarker and early diagnostic tool // Curr. Mol. Med. 2022. V. 22. P. 250–262. doi: 10.2174/1566524021666210315124438
  22. Gorbunova V., Seluanov A., Mita P. et al. The role of retrotransposable elements in ageing and age-associated diseases // Nature. 2021. V. 596. P. 43–53. doi: 10.1038/s41586-021-03542-y
  23. Wei G., Qin S., Li W. et al. MDTE DB: A database for microRNAs derived from Transposable element // IEEE/ACM Trans. Comput. Biol. Bioinform. 2016. V. 13. P. 1155–1160. doi: 10.1109/TCBB.2015.2511767
  24. Autio A., Nevalainen T., Mishra B.H. et al. Effect of aging on the transcriptomic changes associated with the expression of the HERV-K (HML-2) provirus at 1q22 // Immun. Ageing. 2020. V. 17. P. 11. doi: 10.1186/s12979-020-00182-0
  25. Cardelli M. The epigenetic alterations of endogenous retroelements in aging // Mech. Ageing Dev. 2018. V. 174. P. 30–46. doi: 10.1016/j.mad.2018.02.002
  26. Noz M.P., Hartman Y.A.W., Hopman M.T.E. et al. Sixteen-week physical activity intervention in subjects with increased cardiometabolic risk shifts innate immune function towards a less proinflammatory state // J. Am. Heart. Assoc. 2019. V. 8. doi: 10.1161/JAHA.119.013764
  27. Laufs U., Wassmann S., Czech T. et al. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis // Arteriosclerosis, Thrombosis, and Vascular Biology. 2005. V. 25. P. 809–814.
  28. Starkie R., Ostrowski S.R., Jauffred S. et al. Exercise and IL-6 infusion inhibit endotoxininduced TNF-alpha production in humans // FASEB J. 2003. V. 17. P. 884–886.
  29. Kohut M.L., McCann D.A., Russell D.W. et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults // Brain Behav. Immun. 2006. V. 20. P. 201–209.
  30. Pinto P.R., Rocco D.D., Okuda L.S. et al. Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta // Lipids Health Dis. 2015. V. 14. P. 109.
  31. Kadoglou N.P., Kostomitsopoulos N., Kapelouzou A. et al. Effects of exercise training on the severity and composition of atherosclerotic plaque in apoE-deficient mice // J. Vasc. Res. 2011. V. 48. P. 347–356. doi: 10.1159/000321174
  32. Moustardas P., Kadoglou N.P., Katsimpoulas M. et al. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice // PLoS One. 2014. V. 9. doi: 10.1371/journal.pone.0108240
  33. Frodermann V., Rohde D., Courties G. et al. Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells // Nat. Med. 2019. V. 25. P. 1761–1771. doi: 10.1038/s41591-019-0633-x
  34. Stanton K.M., Liu H., Kienzle V. et al. The effects of exercise on plaque volume and composition in a mouse model of early and late life atherosclerosis // Front. Cardiovasc. Med. 2022. V. 9. doi: 10.3389/fcvm.2022.837371
  35. Klein S., Coyle E.F., Wolfe R.R. Fat metabolism during low-intensity exercise in endurance-trained and untrained men // Am. J. Physiol. 1994. V. 267. doi: 10.1152/ajpendo.1994.267.6.E934.
  36. McDermott M.M., Spring B., Tian L. et al. Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: The LITE randomized clinical trial // JAMA. 2021. V. 325. P. 1266–1276. doi: 10.1001/jama.2021.2536
  37. Ingwersen M., Kunstmann I., Oswald C. et al. Exercise training for patients with peripheral arterial occlusive disease // Dtsch. Arztebl. Int. 2023. V. 120. P. 879–885. doi: 10.3238/arztebl.m2023.0231
  38. Wu X.D., Zeng K., Liu W.L. et al. Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis // Int. J. Sports Med. 2014. V. 35. P. 344–350. doi: 10.1055/s-0033-1349075
  39. Wang D., Wang Y., Ma J. et al. MicroRNA-20a participates in the aerobic exercise-based prevention of coronary artery disease by targeting PTEN // Biomed. Pharmacother. 2017. V. 95. P. 756–763. doi: 10.1016/j.biopha.2017.08.086
  40. Cai Y., Xie K.L., Zheng F., Liu S.X. Aerobic exercise prevents insulin resistance through the regulation of miR-492/resistin axis in aortic endothelium // J. Cardiovasc. Transl. Res. 2018. V. 11. P. 450–458. doi: 10.1007/s12265-018-9828-7
  41. Taraldsen M.D., Wiseth R., Videm V. et al. Associations between circulating microRNAs and coronary plaque characteristics: potential impact from physical exercise // Physiol. Genomics. 2022. V. 54. P. 129–140. doi: 10.1152/physiolgenomics.00071.2021
  42. Da Silva N.D. Jr., Andrade-Lima A., Chehuen M.R. et al. Walking training increases microRNA-126 expression and muscle capillarization in patients with peripheral artery disease // Genes (Basel). 2022. V. 14. doi: 10.3390/genes14010101
  43. Sieland J., Niederer D., Engeroff T. et al. Changes in miRNA expression in patients with peripheral arterial vascular disease during moderate- and vigorous-intensity physical activity // Eur. J. Appl. Physiol. 2023. V. 123. P. 645–654. doi: 10.1007/s00421-022-05091-2
  44. Sun Y., Wu Y., Jiang Y., Liu H. Aerobic exercise inhibits inflammatory response in atherosclerosis via Sestrin 1 protein // Exp. Gerontol. 2021. V. 155. doi: 10.1016/j.exger.2021.111581
  45. Lenhare L., Crisol B.M., Silva V.R.R. et al. Physical exercise increases Sestrin 2 protein levels and induces autophagy in the skeletal muscle of old mice // Exp. Gerontol. 2017. V. 97. P. 17–21. doi: 10.1016/j.exger.2017.07.009
  46. Narkar V.A., Downes M., Yu R.T. et al. AMPK and PPARdelta agonists are exercise mimetics // Cell. 2008. V. 134. P. 405–415. doi: 10.1016/j.cell.2008.06.051
  47. Guizoni D.M., Dorighello G.G., Oliveira H.C.F. et al. Aerobic exercise training protects against endothelial dysfunction by increasing nitric oxide and hydrogen peroxide production in LDL receptor-deficient mice // J. Translational Med. 2016. V. 14. P. 213.
  48. De Cecco M., Ito T., Petrashen A.P. et al. L1 drives IFN in senescent cells and promotes age-associated inflammation // Nature. 2019. V. 566. P. 73–78. doi: 10.1038/s41586-018-0784-9
  49. Russ E., Mikhalkevich N., Iordanskiy S. Expression of human endogenous retrovirus group K (HERV-K) HML-2 correlates with immune activation of macrophages and type I interferon response // Microbiol. Spectr. 2023. V. 11. doi: 10.1128/spectrum.04438-22
  50. Laderoute M. The paradigm of immunosenescence in atherosclerosis-cardiovascular disease (ASCVD) // Discov. Med. 2020. V. 29(156). P. 41–51.
  51. Chai J.T., Ruparelia N., Goel A. et al. Differential gene expression in macrophages from human atherosclerotic plaques shows convergence on pathways implicated by genome-wide association study risk variants // Arterioscler. Thromb. Vasc. Biol. 2018. V. 38. P. 2718–2730. doi: 10.1161/ATVBAHA.118.311209
  52. Matsuzawa A., Lee J., Nakagawa S. et al. HERV-Derived Ervpb1 is conserved in simiiformes, exhibiting expression in hematopoietic cell lineages including macrophages // Int. J. Mol. Sci. 2021. V. 22. doi: 10.3390/ijms22094504
  53. Ferrari L., Vicenzi M., Tarantini L. et al. Effects of physical exercise on endothelial function and DNA methylation // Int. J. Environ. Res. Public. Health. 2019. V. 16. doi: 10.3390/ijerph16142530
  54. Romero M.A., Mumford P.W., Roberson P.A. et al. Translational significance of the LINE-1 jumping gene in skeletal muscle // Exerc. Sport. Sci. Rev. 2022. V. 50. P. 185–193. doi: 10.1249/JES.0000000000000301
  55. Wahl D., Cavalier A.N., Smith M. et al. Healthy aging interventions reduce repetitive element transcripts // J. Gerontol. A. Biol. Sci. Med. Sci. 2021. V. 76. P. 805–810. doi: 10.1093/gerona/glaa302
  56. Huang S., Tao X., Yuan S. et al. Discovery of an active RAG transposon illuminates the origins of V(D)J recombination // Cell. 2016. V. 166. P. 102–114. doi: 10.1016/j.cell.2016.05.032
  57. Rivera-Munoz P., Malivert L., Derdouch S. et al. DNA repair and the immune system: From V(D)J recombination to aging lymphocytes // Eur. J. Immunol. 2007. V. 37. S71–S82. doi: 10.1002/eji.200737396
  58. Chuong E.B. The placenta goes viral: Retroviruses control gene expression in pregnancy // PLoS Biol. 2018. V. 16. doi: 10.1371/journal.pbio.3000028
  59. Chuong E.B., Elde N.C., Feschotte C. Regulatory evolution of innate immunity through co-option of endogenous retroviruses // Science. 2016. V. 351. P. 1083–1087.
  60. De la Hera B., Varade J., Garcia-Montojo M. et al. Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: Study in the Spanish population and meta-analysis // PLoS One. 2013. V. 8. doi: 10.1371/journal.pone.0062090.
  61. Martinez-Ceballos M.A., Rey J.C.S., Alzate-Granados J.P. et al. Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis // Atherosclerosis. 2021. V. 335. P. 68–76. doi: 10.1016/j.atherosclerosis.2021.09.017
  62. Johnson R., Guigo R. The RIDL hypothesis: Transposable elements as functional domains of long noncoding RNAs // RNA. 2014. V. 20. P. 959–976. doi: 10.1261/rna.044560.114
  63. Мустафин Р.Н., Хуснутдинова Э.К. Некодирующие части генома как основа эпигенетической наследственности // Вавил. журн. генетики и селекции. 2017. Т. 21. С. 742–749.
  64. Feschotte C. Transposable elements and the evolution of regulatory networks // Nat. Rev. Genet. 2008. V. 9. P. 397–405.
  65. Мустафин Р.Н. Взаимосвязь транспозонов с транскрипционными факторами в эволюции эукариот // Журн. эвол. биохимии и физиологии. 2019. Т. 55. № 1. С. 14–22.
  66. Lee D.Y., Chiu J.J. Atherosclerosis and flow: Roles of epigenetic modulation in vascular endothelium // J. Biomed. Sci. 2019. V. 26. P. 56. doi: 10.1186/s12929-019-0551-8
  67. Samantarrai D., Dash S., Chhetri B. et al. Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer // Mol. Cancer Res. 2013. V. 11. Р. 315–328.
  68. Мустафин Р.Н., Хуснутдинова Э.К. Стресс-индуцированная активация транспозонов в экологическом морфогенезе // Вавил. журн. генетики и селекции. 2019. T. 23. C. 380–389.
  69. Lu X., Sachs F., Ramsay L. et al. The retrovirus HERVH is a long noncoding RNA required for human embryonic stem cell identity // Nat. Struct. Mol. Biol. 2014. V. 21. P. 423–425. doi: 10.1038/nsmb.2799
  70. Honson D.D., Macfarlan T.S. A lncRNA-like role for LINE1s in development // Dev. Cell. 2018. V. 46. P. 132–134. doi: 10.1016/j.devcel.2018.06.022
  71. Hueso M., Cruzado J.M., Torras J. et al. ALU minating the path of atherosclerosis progression: Chaos theory suggests a role for alu repeats in the development of atherosclerotic vascular disease // Int. J. Mol. Sci. 2018. V. 19. doi: 10.3390/ijms19061734
  72. Chi J.S., Li J.Z., Jia J.J. et al. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis // J. Huazhong. Univ. Sci. Technol. Med. Sci. 2017. V. 7. P. 816–822. doi: 10.1007/s11596-017-1812-y
  73. Holdt L.M., Hoffmann S., Sass K. et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks // PLoS Genet. 2013. V. 9. doi: 10.1371/journal.pgen.1003588
  74. Simion V., Zhou H., Haemming S. et al. A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus // Nat. Commun. 2020. V. 11. P. 6135. doi: 10.1038/s41467-020-19664-2
  75. Pan J.X. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway // Eur. Rev. Med. Pharmacol. Sci. 2017. V. 21. P. 322–328.
  76. Bai J., Liu J., Fu Z. et al. Silencing lncRNA AK136714 reduces endothelial cell damage and inhibits atherosclerosis // Aging. 2021. V. 13. P. 14159–14169. doi: 10.18632/aging.203031
  77. Sun C., Fu Y., Gu X. et al. Macropahge-enriched lncRNA RAPIA: A novel therapeutic target for atherosclerosis // Arterioscler. Thromb. Vasc. Biol. 2020. V. 40. P. 1464–1478. doi: 10.1161/ATVBAHA.119.313749
  78. Vlachogiannis N.I., Sachse M., Georgiopoulos G. et al. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease // J. Mol. Cell. Cardiol. 2021. V. 160. P. 111–120. doi: 10.1016/j.yjmcc.2021.07.005
  79. Ye Z.M., Yang S., Xia Y. et al. LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation // Cell. Death. Dis. 2019. V. 10. P. 138. doi: 10.1038/s41419-019-1409-4
  80. Kapusta A., Kronenberg Z., Lynch V.J. et al. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs // PLoS Genet. 2013. V. 9. doi: 10.1371/journal.pgen.1003470
  81. Pan D., Liu G., Li B. et al. MicroRNA-1246 regulates proliferation, invasion, and differentiation in human vascular smooth muscle cells by targeting cystic fibrosis transmembrane conductance regulator (CFTR) // Pflugers. Arch. 2021. V. 473. P. 231–240. doi: 10.1007/s00424-020-02498-8
  82. Marasa B.S., Srikantan S., Martindale J.L. et al. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence // Aging (Albany NY). 2010. V. 2. P. 333–343. doi: 10.18632/aging.100159
  83. Dhahbi J.M., Atamna H., Boffelli D. et al. Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence // PLoS One. 2011. V. 6. doi: 10.1371/journal.pone.0020509
  84. Lin F.Y., Tsai Y.T., Huang C.Y. et al. GroEL of Porphyromonas gingivalis-induced microRNAs accelerate tumor neovascularization by downregulating thrombomodulin expression in endothelial progenitor cells // Mol. Oral. Microbiol. 2023. V. 39. P. 47–61. doi: 10.1111/omi.12415
  85. Noren Hooten N., Fitzpatrick M., Wood W.H. et al. Age related changes in microRNA levels in serum // Aging (Albany NY). 2013. V. 5. P. 725–740.
  86. Long R., Gao L., Li Y. et al. M2 macrophage-derived exosomes carry miR-1271-5p to alleviate cardiac injury in acute myocardial infarction through down-regulating SOX6 // Mol. Immunol. 2021. V. 136. P. 26–35. doi: 10.1016/j.molimm.2021.05.006
  87. Wang R., Dong L.D., Meng X.B. et al. Unique microRNA signatures associated with early coronary atherosclerotic plaques // Biochem. Biophys. Res. Commun. 2015. V. 464. P. 574–579. doi: 10.1016/j.bbrc.2015.07.010
  88. Tan K.S., Armugam A., Sepramaniam S. et al. Expression profile of microRNAs in young stroke patients // PLoS One. 2009. V. 4. e7689.
  89. Chen F., Ye X., Jiang H. et al. MicroRNA-151 attenuates apoptosis of endothelial cells induced by oxidized low-density lipoprotein by targeting interleukin-17A (IL-17A) // J. Cardiovasc. Transl. Res. 2021. 14. P. 400–408. doi: 10.1007/s12265-020-10065-w
  90. Zhao L., Wang B., Sun L. et al. Association of miR-192-5p with atherosclerosis and its effect on proliferation and migration of vascular smooth muscle cells // Mol. Biotechnol. 2021. V. 63. P. 1244–1251. doi: 10.1007/s12033-021-00376-x
  91. Tsukamoto H., Kouwaki T., Oshiumi H. Aging-associated extracellular vesicles contain immune regulatory microRNAs alleviating hyperinflammatory state and immune dysfunction in the Elderly // iScience. 2020. V. 23. doi: 10.1016/j.isci.2020.101520
  92. Zhang Y., Wang H., Xia Y. The expression of miR-211-5p in atherosclerosis and its influence on diagnosis and prognosis // BMC Cardiovasc. Disord. 2021. V. 21. P. 371. doi: 10.1186/s12872-021-02187-z
  93. Smith-Vikos T., Liu Z., Parsons C. A serum miRNA profile of human longevity: Findings from the Baltimore Longitudinal Study of Aging (BLSA) // Aging (Albany NY). 2016. V. 8(11). P. 2971–2987. doi: 10.18632/aging.101106
  94. Miller C.L., Haas U., Diaz R. et al. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation // PLoS Genet. 2014. V. 10. doi: 10.1371/journal.pgen.1004263
  95. Francisco S., Martinho V., Ferreira M. et al. The role of microRNAs in proteostasis decline and protein aggregation during brain and skeletal muscle aging // Int. J. Mol. Sci. 2022. V. 23. P. 3232.
  96. Liu D., Sun X., Ye P. MiR-31 overexpression exacerbates atherosclerosis by targeting NOX4 in apoE(-/-) Mice // Clin. Lab. 2015. V. 61. P. 1617–1624. doi: 10.7754/clin.lab.2015.150322
  97. Yu Y., Zhang X., Liu F. et al. A stress-induced miR-31-CLOCK-ERK pathway is a key driver and therapeutic target for skin aging // Nat. Aging. 2021. V. 1. P. 795–809. doi: 10.1038/s43587-021-00094-8
  98. Lu X., Yang B., Yang H. et al. MicroRNA-320b modulates cholesterol efflux and atherosclerosis // J. Atheroscler. Thromb. 2022. V. 29. P. 200–220. doi: 10.5551/jat.57125
  99. Dalmasso B., Hatse S., Brouwers B. et al. Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy // BMC Cancer. 2018. V. 18. P. 1014. doi: 10.1186/s12885-018-4920-6
  100. Wang L., Zheng Z., Feng X. et al. CircRNA/lncRNA-miRNA-mRNA network in Oxidized, Low-Density, Lipoprotein-Induced Foam Cells // DNA Cell. Biol. 2019. V. 38. P. 1499–1511. doi: 10.1089/dna.2019.4865
  101. Yang X., Tan J., Shen J. et al. Endothelial cell-derived extracellular vesicles target TLR4 via miRNA-326-3p to regulate skin fibroblasts senescence // J. Immunol. Res. 2022. V. 2022. doi: 10.1155/2022/3371982
  102. Hildebrandt A., Kirchner B., Meidert A.S. et al. Detection of atherosclerosis by small RNA-sequencing analysis of extracellular vesicle enriched serum samples // Front. Cell. Dev. Biol. 2021. V. 9. doi: 10.3389/fcell.2021.729061
  103. Liu Y., Lai P., Deng J. et al. Micro-RNA335-5p targeted inhibition of sKlotho and promoted oxidative stress-mediated aging of endothelial cells // Biomark. Med. 2019. V. 13. P. 457–466. doi: 10.2217/bmm-2018-0430
  104. Raihan O., Brishti A., Molla M.R. et al. The Age-dependent elevation of miR-335-3p Leads to reduced cholesterol and impaired memory in brain // Neuroscience. 2018. V. 390. P. 160–173. doi: 10.1016/j.neuroscience.2018.08.003
  105. Schiano C., Benincasa G., Franzese M. et al. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases // Pharmacol. Ther. 2020. V. 210. doi: 10.1016/j.pharmthera.2020.107514
  106. Wang W., Ma F., Zhang H. MicroRNA-374 is a potential diagnostic biomarker for atherosclerosis and regulates the proliferation and migration of vascular smooth muscle cells // Cardiovasc. Diagn. Ther. 2020. V. 10. P. 687–694. doi: 10.21037/cdt-20-444
  107. Shao D., Lian Z., Di Y. et al. Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and inflammation via miRNA // NPJ Sci. Food. 2018. V. 2. P. 13. doi: 10.1038/s41538-018-0022-8
  108. Allen R.M., Vickers K.C. Coenzyme Q10 increases cholesterol efflux and inhibits atherosclerosis through microRNAs // Arterioscler. Thromb. Vasc. Biol. 2014. V. 34. P. 1795–1797.
  109. Proctor C.J., Goljanek-Whysall K. Using computer simulation models to investigate the most promising microRNAs to improve muscle regeneration during ageing // Sci. Rep. 2017. V. 7. P. 12314. doi: 10.1038/s41598-017-12538-6
  110. Li X., Wu J., Zhang K. et al. MiR-384-5p Targets Gli2 and negatively regulates age-related osteogenic differentiation of rat bone marrow mesenchymal stem cells // Stem. Cells Dev. 2019. V. 28. P. 791–798. doi: 10.1089/scd.2019.0044
  111. Wang B., Zhong Y., Huang D. et al. Macrophage autophagy regulated by miR-384-5p-mediated control of Beclin-1 plays a role in the development of atherosclerosis // Am. J. Transl. Res. 2016. V. 8. P. 606–614.
  112. Yang J., Liu H., Cao Q. et al. Characteristics of CXCL2 expression in coronary atherosclerosis and negative regulation by microRNA-421 // J. Int. Med. Res. 2020. V. 48. doi: 10.1177/0300060519896150
  113. Li G., Song H., Chen L. et al. TUG1 promotes lens epithelial cell apoptosis by regulating miR-421/caspase-3 axis in age-related cataract // Exp. Cell. Res. 2017. V. 356. P. 20–27. doi: 10.1016/j.yexcr.2017.04.002
  114. Liang X., Hu M., Yuan W. et al. MicroRNA-4487 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting RAS p21 protein activator 1 // Pathol. Res. Pract. 2022. V. 234. doi: 10.1016/j.prp.2022.153903
  115. Wang L., Si X., Chen S. et al. A comprehensive evaluation of skin aging-related circular RNA expression profiles // J. Clin. Lab. Anal. 2021. V. 35. doi: 10.1002/jcla.23714
  116. Niu M., Li H., Li X. et al. Circulating exosomal miRNAs as novel biomarkers perform superior diagnostic efficiency compared with plasma miRNAs for large-artery atherosclerosis stroke // Front. Pharmacol. 2021. V. 12. doi: 10.3389/fphar.2021.791644
  117. Chen J., Zou Q., Lv D. et al. Comprehensive transcriptional landscape of porcine cardiac and skeletal muscles reveals differences of aging // Oncotarget. 2018. V. 9. P. 1524–1541.
  118. Konwerski M., Gromadka A., Arendarczyk A. et al. Atherosclerosis pathways are activated in pericoronary adipose tissue of patients with coronary artery disease // J. Inflamm. Res. 2021. V. 14. P. 5419–5431. doi: 10.2147/JIR.S326769
  119. Fang M., Zhou Q., Tu W. et al. ATF4 promotes brain vascular smooth muscle cells proliferation, invasion and migration by targeting miR-552-SKI axis // PLoS One. 2022. V. 17. doi: 10.1371/journal.pone.0270880
  120. Breunig S., Wallner V., Kobler K. et al. The life in a gradient: Calcium, the lncRNA SPRR2C and mir542/mir196a meet in the epidermis to regulate the aging process // Aging (Albany NY). 2021. V. 13. P. 19127–19144. doi: 10.18632/aging.203385
  121. Zhang M., Zhu Y., Zhu J. et al. Circ_0086296 induced atherosclerotic lesions via the IFIT1/STAT1 feedback loop by sponging miR-576-3p // Cell. Mol. Biol. Lett. 2022. V. 27. P. 80. doi: 10.1186/s11658-022-00372-2
  122. Kim T.K., Jeon S., Park S. et al. 2’-5’ oligoadenylate synthetase-like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability // Nat. Commun. 2022. V. 13. P. 6647. doi: 10.1038/s41467-022-34433-z
  123. Chen L.J., Chuang L., Huang Y.H. et al. MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress // Circ. Res. 2015. V. 116. P. 1157–1169. doi: 10.1161/CIRCRESAHA.116.305987
  124. Castanheira C.I.G.D., Anderson J.R., Fang Y. et al. Mouse microRNA signatures in joint ageing and post-traumatic osteoarthritis // Osteoarthr. Cartil Open. 2021. V. 3. doi: 10.1016/j.ocarto.2021.100186
  125. Saenz-Pipaon G., Dichek D.A. Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases // Atherosclerosis. 2023. V. 374. P. 44–54. doi: 10.1016/j.atherosclerosis.2022.12.003
  126. Xu X., Li H. Integrated microRNA-gene analysis of coronary artery disease based on miRNA and gene expression profiles // Mol. Med. Rep. 2016. V. 13. P. 3063–3073.
  127. Xu D., Liu T., He L. et al. LncRNA MEG3 inhibits HMEC-1 cells growth, migration and tube formation via sponging miR-147 // Biol. Chem. 2020. V. 401. P. 601–615. doi: 10.1515/hsz-2019-0230
  128. Maes O.C., Sarojini H., Wang E. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts // J. Cell. Physiol. 2009. V. 221. P. 109–119. doi: 10.1002/jcp.21834.
  129. Liu J., Liu Y., Sun Y.N. et al. MiR-28-5p involved in LXR-ABCA1 pathway is increased in the plasma of unstable angina patients // Heart. Lung. Circ. 2015. V. 24. P. 724–730. doi: 10.1016/j.hlc.2014.12.160
  130. Morsiani C., Bacalini M.G., Collura S. et al. Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down syndrome // Mech. Ageing Dev. 2022. V. 206. doi: 10.1016/j.mad.2022.111691
  131. Pu Y., Zhao Q., Men X. et al. MicroRNA-325 facilitates atherosclerosis progression by mediating the SREBF1/LXR axis via KDM1A // Life Sci. 2021. V. 277. doi: 10.1016/j.lfs.2021.119464.
  132. Zhao J., Li C., Qin T. et al. Mechanical overloading-induced miR-325-3p reduction promoted chondrocyte senescence and exacerbated facet joint degeneration // Arthritis Res. Ther. 2023. V. 25. P. 54. doi: 10.1186/s13075-023-03037-3
  133. Owczarz M., Polosak J., Domaszewska-Szostek A. et al. Age-related epigenetic drift deregulates SIRT6 expression and affects its downstream genes in human peripheral blood mononuclear cells // Epigenetics. 2020. V. 15. P. 1336–1347. doi: 10.1080/15592294.2020.1780081
  134. Ahmadi R., Heidarian E., Fadaei R. et al. MiR-342-5p expression levels in coronary artery disease patients and its association with inflammatory cytokines // Clin. Lab. 2018. V. 64. P. 603–609. doi: 10.7754/Clin.Lab.2017.171208
  135. Rafiq M., Dandare A., Javed A. et al. Competing endogenous RNA regulatory networks of hsa_circ_0126672 in pathophysiology of coronary heart disease // Genes (Basel). 2023. V. 14. doi: 10.3390/genes14030550
  136. Fu D.N., Wang Y., Yu L.J. et al. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5 // Exp. Cell. Res. 2021. V. 401. doi: 10.1016/j.yexcr.2021.112519
  137. Li X., Song Y., Liu D. et al. MiR-495 promotes senescence of mesenchymal stem cells by targeting Bmi-1 // Cell. Physiol. Biochem. 2017. V. 42. P. 780–796. doi: 10.1159/000478069
  138. Salerno A.G., van Solingen C., Scotti E. et al. LDL receptor pathway regulation by miR-224 and miR-520d // Front. Cardiovasc. Med. 2020. V. 7. P. 81.
  139. Yu M., He X., Liu T. et al. lncRNA GPRC5D-AS1 as a ceRNA inhibits skeletal muscle aging by regulating miR-520d-5p // Aging (Albany NY). 2023. V. 15. P. 13980–13997. doi: 10.18632/aging.205279.
  140. Hou X., Dai H., Zheng Y. Circular RNA hsa_circ_0008896 accelerates atherosclerosis by promoting the proliferation, migration and invasion of vascular smooth muscle cells via hsa-miR-633/CDC20B (cell division cycle 20B) axis // Bioengineered. 2022. V. 13. P. 5987–5998. doi: 10.1080/21655979.2022.2039467
  141. Ma G., Bi S., Zhang P. Long non-coding RNA MIAT regulates ox-LDL-induced cell proliferation, migration and invasion by miR-641/STIM1 axis in human vascular smooth muscle cells // BMC Cardiovasc. Disord. 2021. V. 21. P. 248. doi: 10.1186/s12872-021-02048-9
  142. Huang R., Hu Z., Cao Y. et al. MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting Cyclin D2 expression // EBioMedicine. 2019. V. 40. P. 685–694. doi: 10.1016/j.ebiom.2019.01.032
  143. Liu H., Zuo C., Cao L. et al. Inhibition of miR-652-3p regulates lipid metabolism and inflammatory cytokine secretion of macrophages to alleviate atherosclerosis by improving TP53 expression // Mediators Inflamm. 2022. V. 2022. doi: 10.1155/2022/9655097

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Scheme of the role of microRNA in the mechanisms of atherosclerosis development.

Download (414KB)
Indexing metadata
3. Fig. 2. Schematic representation of the effects of physical exercise on the expression of microRNAs involved in the pathogenesis of atherosclerosis.

Download (480KB)
Indexing metadata
4. Fig. 3. Scheme of interaction of mobile genetic elements with non-coding RNA (ncRNA) in the pathogenesis of atherosclerosis.

Download (147KB)
Indexing metadata

Copyright (c) 2024 Russian Academy of Sciences